Gilteritinib usage and dosage
Gilteritinib is an antineoplastic agent indicated for the treatment of FDA-approved tests found to detect FMS-like tyrosine kinase3 Adult patients with relapsed or refractory acute myeloid leukemia(AML)mutated (FLT3). How to take Giritinib (Giritinib) and how much should you take?
Gilatinib is an oral tablet. The instructions recommend a starting dose of 120 mg once daily, with or without food. In the absence of disease progression or unacceptable toxicity, treatment is recommended for at least 6 months to produce a clinical response.
Take Gtinib at about the same time each day. Carefully follow the instructions on the prescription label and take Gtinib exactly as directed. Do not take more or less than the number prescribed by your doctor. When taking Swallow the tablets whole with water Do not cut, chew or crush them. Your doctor may adjust the dose, or stop treatment temporarily or permanently. If the drug is not working well or any side effects occur, tell your doctor how you are feeling during treatment. If you continue taking GIRItinib even if you feel well, do not stop taking GIRITINI without talking to your doctor. Safety and effectiveness in pediatric patients while taking this medication have not been established. Among the 319 patients in the giritinibclinical study, 43% were aged
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)